BRAF and thymoma: For example, for thymomas the CIMLR subtypes perform better at predicting survival than histological classification (Supplementary Note 2), while the CIMLR subtypes of cutaneous melanoma are much better at predicting survival than classification based on BRAF, RAS, and NF1 mutations.